ArticleFrontiers in pharmacology2025

hnRNP A2B1 as a promising therapeutic target for radiomodulatory drug development: evidence from computational and experimental studies.

N S Lubinets et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.